Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Net assets
Net assets on the balance sheet as of June 2023 : $0.62 B
According to Mallinckrodt Pharmaceuticals
's latest financial reports the company has $0.62 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Mallinckrodt Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $1.61 B | 414.9% |
| 2021-12-31 | $0.31 B | -69.25% |
| 2020-12-31 | $1.01 B | -47.48% |
| 2019-12-31 | $1.94 B | -32.78% |
| 2018-12-31 | $2.88 B | -55.73% |
| 2017-12-31 | $6.52 B | |
| 2016-09-30 | $5.27 B | -0.76% |
| 2015-09-30 | $5.31 B | 7.12% |
| 2014-09-30 | $4.95 B | 294.87% |
| 2013-09-30 | $1.25 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 10,896.80% | 🇺🇸 USA |
 General Electric GE | $31.10 B | 4,873.30% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 1,199.33% | 🇮🇱 Israel |